NextGen Healthcare, Inc. (NXGN): Price and Financial Metrics


NextGen Healthcare, Inc. (NXGN): $14.59

0.06 (+0.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NXGN POWR Grades


  • NXGN scores best on the Value dimension, with a Value rank ahead of 92.62% of US stocks.
  • NXGN's strongest trending metric is Growth; it's been moving down over the last 48 weeks.
  • NXGN ranks lowest in Momentum; there it ranks in the 63rd percentile.

NXGN Stock Summary

  • With a price/earnings ratio of 75.09, Nextgen Healthcare Inc P/E ratio is greater than that of about 88.83% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of -87.41%, Nextgen Healthcare Inc's debt growth rate surpasses just 2.9% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for NXGN comes in at 17.85% -- higher than that of 87.65% of stocks in our set.
  • Stocks that are quantitatively similar to NXGN, based on their financial statements, market capitalization, and price volatility, are MBII, AMSC, NSPR, AGE, and NURO.
  • Visit NXGN's SEC page to see the company's official filings. To visit the company's web site, go to www.nextgen.com.

NXGN Valuation Summary

  • NXGN's price/sales ratio is 1.8; this is 66.04% lower than that of the median Technology stock.
  • Over the past 243 months, NXGN's price/earnings ratio has gone up 61.6.
  • Over the past 243 months, NXGN's price/earnings ratio has gone up 61.6.

Below are key valuation metrics over time for NXGN.

Stock Date P/S P/B P/E EV/EBIT
NXGN 2021-09-01 1.8 2.4 78.8 68.2
NXGN 2021-08-31 1.8 2.3 77.8 67.4
NXGN 2021-08-30 1.8 2.3 77.9 67.4
NXGN 2021-08-27 1.8 2.4 79.9 69.2
NXGN 2021-08-26 1.7 2.2 74.7 64.6
NXGN 2021-08-25 1.7 2.3 75.3 65.1

NXGN Growth Metrics

  • The 5 year price growth rate now stands at -31.63%.
  • Its 5 year net income to common stockholders growth rate is now at -76.64%.
  • The 5 year revenue growth rate now stands at 8.19%.
Over the past 52 months, NXGN's revenue has gone up $62,402,000.

The table below shows NXGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 572.026 81.159 13.187
2021-03-31 556.821 98.518 9.515
2020-12-31 549.015 97.208 5.853
2020-09-30 545.003 92.869 9.804
2020-06-30 539.257 86.276 5.43
2020-03-31 540.239 85.601 7.498

NXGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NXGN has a Quality Grade of B, ranking ahead of 81.76% of graded US stocks.
  • NXGN's asset turnover comes in at 0.881 -- ranking 27th of 83 Computers stocks.
  • EXTR, FFIV, and GDDY are the stocks whose asset turnover ratios are most correlated with NXGN.

The table below shows NXGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.881 0.507 0.125
2021-03-31 0.812 0.505 0.075
2020-12-31 0.779 0.501 0.035
2020-09-30 0.783 0.501 0.044
2020-06-30 0.803 0.502 0.031
2020-03-31 0.870 0.505 0.034

NXGN Price Target

For more insight on analysts targets of NXGN, see our NXGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.38 Average Broker Recommendation 1.85 (Hold)

NXGN Stock Price Chart Interactive Chart >

Price chart for NXGN

NXGN Price/Volume Stats

Current price $14.59 52-week high $23.80
Prev. close $14.53 52-week low $12.12
Day low $14.56 Volume 213,664
Day high $14.84 Avg. volume 331,025
50-day MA $15.42 Dividend yield N/A
200-day MA $17.80 Market Cap 982.37M

NextGen Healthcare, Inc. (NXGN) Company Bio


NextGen Healthcare (formerly Quality Systems) develops and markets computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. The company was founded in 1974 and is based in Irvine, California.


NXGN Latest News Stream


Event/Time News Detail
Loading, please wait...

NXGN Latest Social Stream


Loading social stream, please wait...

View Full NXGN Social Stream

Latest NXGN News From Around the Web

Below are the latest news stories about Nextgen Healthcare Inc that investors may wish to consider to help them evaluate NXGN as an investment opportunity.

The Razin Group Issues Presentation Detailing the Need to Reset the Balance of Power in NextGen Healthcare’s Dysfunctional and Insular Boardroom

IRVINE, Calif., September 24, 2021--Sheldon Razin, who collectively with Lance Rosenzweig and the other participants in his solicitation (collectively, the "Razin Group") owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (NASDAQ: NXGN) ("NextGen Healthcare" or the "Company"), today issued a 70-page presentation that details the case for resetting the balance of power on NextGen Healthcare's nine-member Board of Directors (the "Board"). The Razin Group urges sh

Yahoo | September 24, 2021

NextGen's (NXGN) New Partnership to Boost Patient Experience

NextGen (NXGN) collaborates with Clinect Healthcare to extend patient-provider connection.

Yahoo | September 22, 2021

NextGen Healthcare Enables Care Resource Community Health Centers to Improve Patient Experience and Clinical Outcomes

ATLANTA, September 21, 2021--New Partnership with Clinect Puts Patient Satisfaction Front and Center

Yahoo | September 21, 2021

NextGen Healthcare Reports Granting of Inducement Awards

ATLANTA, September 20, 2021--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today stated that the Compensation Committee of the Company’s Board of Directors has approved the grant of inducement awards to David Sides, in connection with his appointment as the Company’s President and Chief Executive Officer, effective on September 22, 2021. In connection with his appointment as the Company’s Chief Growth and Strategy Officer effective on Jul

Yahoo | September 20, 2021

NextGen Healthcare Appoints David Sides President and Chief Executive Officer

ATLANTA, September 20, 2021--NextGen Healthcare announces that David Sides has been appointed President and Chief Executive Officer, effective September 22, 2021.

Yahoo | September 20, 2021

Read More 'NXGN' Stories Here

NXGN Price Returns

1-mo -6.83%
3-mo -12.27%
6-mo -19.39%
1-year 19.30%
3-year -27.34%
5-year 28.55%
YTD -20.01%
2020 13.50%
2019 6.07%
2018 11.56%
2017 3.27%
2016 -18.42%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.3793 seconds.